Klinikum Dortmund gGmbH — Clinical Trial Site

66 Registered trials

35 Currently recruiting

Organisation

Klinikum Dortmund gGmbH

Location

Dortmund, Germany

Identifier

ORG-100017830

Address

Münsterstraße 240, Mitte, 44145, Germany

Departments

#7213;Hautklinik
1114: Klinik für Neurologie
276007: Klinik für Kinder und Jugendmedizin
9194: Hautklinik
Abt. Päd. Onkologie / Hämatologie
Chirurgische Klinik
Clinic for Neurology
Department of Neurology
Department of Otorhinolaryngology, Head and Neck Surgery
Dermatological clinic
Dermatologie
Dermatology
Frauenklinik
Frauenklinik Dortmund
Frauenklinik Klinikum
Gynecologic oncology center
Hautklinik
Kinder- und Jugendmedizin
Kinderonkologie und -Hämatologie
Kinderonkologisches Zentrum
Klinik fuer Gastroenterologie, Haematologie und internistische Onkologie und Endokrinologie
Klinik für An#sthesie und Schmerzmedizin
Klinik für Anästhesielogie, Operative Intensivmedizin
Klinik für Anästhesiologie
Klinik für Chirurgie
Klinik für Dermatologie und Venerologie
Klinik für Gastroenterologie, Hämatologie, Internistische Onkologie und Endokrinologie
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin Kinderhämatologie und -onkologie
Klinik für Kinder- und Jugendmedizin Station K1, Abt. Päd. Onkologie / Hämatologie
Klinik für Neurologie
Klinikum Dortmund
Klinikum Dortmund gGmbH
Klinikzentrum Mitte
Med. Klinik für Hämatologie und Onkologie
Med. Klinik Nord, Pneumologie, Infektiologie, Intensivmedizin
Medizinische Klinik / Onkologie
Nephrology
Neurologische Klinik
Neuroradiologe
Oncology
Oncology for pediatrics
Paedriatrics, Department of Oncology and Hematology
Pediatric Hematology/Oncology
Pediatrics and adolescent medicine
Westfälisches Kinderzentrum
Westfälisches Kinderzentrum - Kinderonkologisches Zentrum
Westfälisches Kinderzentrum Klinik für Kinder- und Jugendmedizin
Westphalian Children's Center

Clinical trials at this site (66)

Search interface

Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants Recruiting

2025-521762-99-00 acute ischemic stroke 5 2026-03-09
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carc… Recruiting

2022-500676-59-00 EBV-positive nasopharyngeal carcinoma 4 2025-12-18
A phase 3 study to evaluate petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of head and neck cancer Recruiting

2023-510323-30-00 First-line treatment of recurrent or metastatic PD-L1+ 5 2025-01-24
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Scabies therapy with two differently concentrated permethrin creams Recruiting

2023-507925-41-00 Scabies 5 2024-08-14
N-PLUS Recruiting

2022-502559-69-01 advanced (FIGO stage IIIA, IIIB, IIIC, or IV of the 201 4 2024-07-04
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
Treatment of Established Status Epilepticus in the Elderly - a prospective, randomized, double-blind comparative effectiveness trial Recruiting

2024-516634-35-00 Convulsive or nonconvulsive benzodiazepine-resistant (e 6 2024-02-01
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::AB 4 2023-07-13
A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) Recruiting

2022-500967-11-00 Previously Untreated Metastatic or Unresectable Melanom 5 2023-07-06
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade… Ended

2024-513266-19-00 Hidradenitis Suppurativa (HS) 5 2025-06-13
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
A trial to learn if rilvegostomig with chemotherapy given after surgery is safe in people with biliary tract cancer and works to delay when … Ended

2023-506054-20-00 Adenocarcinoma of the biliary tract (intrahepatic or ex 5 2024-06-05
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
Adjuvant nivolumab treatment in stage II high-risk melanoma – A randomized, controlled, phase III trial with biomarker-based risk stratifica… Ended

2023-509394-23-00 Stage II melanoma arising from a primary cutaneous site 5 2020-06-12
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02